Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2024-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
2023年年度审计报告
Regulatory Filings
2024-04-26 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Huabang Life Health Co., Ltd. It details the approval of various reports and proposals including the 2023 Supervisory Board Work Report, 2023 Financial Final Report, 2023 Profit Distribution Plan, 2023 Annual Report and its summary, 2024 Q1 Report, internal control self-evaluation report, asset impairment provision, and the reappointment of the audit firm. The document repeatedly states that these reports are published separately on official websites and newspapers, indicating this document itself is not the full reports but a meeting resolution announcing their approval and submission to the shareholders' meeting. The document length is about 2955 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal announcement of supervisory board resolutions and approvals related to various reports, not the reports themselves.
2024-04-26 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2023年度公司内部控制自我评价报告" (2023 Annual Internal Control Self-Evaluation Report) of 华邦生命健康股份有限公司. It discusses the company's internal control evaluation for the fiscal year ending December 31, 2023, including detailed descriptions of internal control environment, risk assessment, control activities, and communication. It also includes conclusions on the effectiveness of internal controls, absence of major deficiencies, and plans for improvement. The document is comprehensive, contains substantive content related to internal control evaluation, and is not merely an announcement or certification. It is not a full annual report (10-K) but a specialized report on internal control evaluation, which aligns with the definition of an Audit Report / Information (AR) as it relates to audit and internal control results. Therefore, the appropriate classification is AR with high confidence. FY 2023
2024-04-26 Chinese
关于计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Huabang Life Health Co., Ltd. regarding the provision for asset impairment losses as of December 31, 2023. It details the amounts and types of impairment provisions made, including credit impairment, inventory write-downs, goodwill impairment, and long-term asset impairment. The document includes board and supervisory committee approvals and audit committee opinions, but it does not contain full financial statements or comprehensive financial performance data. The length is 2518 characters, which is relatively short and the document is primarily an announcement of impairment provisions rather than a full financial report. It is not a full Annual Report (10-K) or Interim Report (IR), nor is it a certification or regulatory filing. The content fits best as a Regulatory Filing (RNS) because it is a formal disclosure of a significant accounting estimate and its impact, but not a full financial report or earnings release. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2024-04-26 Chinese
关于续聘2024年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of the audit firm for the fiscal year 2024. It details the qualifications, experience, and independence of the audit firm, the audit fees, and the approval process by the board and audit committee. It does not contain any actual audit report or financial statements but is a formal notice about the selection of the audit institution for the upcoming year. The document length is 3450 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits the category of Audit Report / Information (AR), as it relates specifically to audit matters but is not a full annual report or audit report itself. However, since it is an announcement about the audit firm appointment and not the audit report or results, it is best classified as an Audit Report / Information (AR) filing type, which covers standalone audit-related announcements excluding full annual reports. FY 2024
2024-04-26 Chinese
2023年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the 2023 annual financial settlement report of 华邦生命健康股份有限公司, containing detailed audited financial statements, including income statement, balance sheet, cash flow statement, and financial ratios for the full year 2023. It mentions the audit by 四川华信会计师事务所 with an unqualified opinion, and provides comprehensive financial data and analysis for the year. The length is over 6,000 characters and contains substantive financial data, not just an announcement or certification. This matches the definition of an Annual Report (10-K) which covers company activity and full financial performance for the year. FY 2023
2024-04-26 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.